The transaction, expected to close in Q3 or Q4, will take the company private after nearly 100 years as a public company.

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement rates for prescription drugs.

Investing.com - Walgreens Boots Alliance (NASDAQ:WBA) posted third-quarter earnings and sales that topped estimates, as cost savings helped to offset front-end sales at the likely soon-to-be private ...

Both CVS and Walgreens have seen their front-of-store sales struggle for years, aside from a COVID bump fueled by vaccine-driven foot traffic in 2021. But retail is much more important to ...

Walgreens stock plummeted 56% in 2024, but has potential for high dividend yields amidst challenges. ... Walgreens’ front-of-store offerings only generate about a fourth of the firm’s sales.

Walgreens has embarked on a $1 billion cost-cutting program under CEO Tim WentworthTim Wentworth Business Wire. It currently employs 312,000 people in 12,000 stores in eight countries, according ...

CVS and Walgreens grew massive nationwide footprints of more than 9,000 and 8,000 stores, respectively. They gobbled up mom-and-pop shops and signed long-term leases for prime locations on street ...

Walgreens Boots Alliance plans to close 1,200 stores during the next three years, with 500 closures set for next year, in the face of low drug reimbursement rates and slower consumer spending.

Retail pharmacy giant Walgreen Co must pay more than $987 million to satisfy an arbitration award won by telemedicine provider PWNHealth, a federal judge in Delaware ruled on Monday.